Application of nicotinic acid derivatives in relieving female reproductive system aging injury
A reproductive system and derivative technology, applied in the fields of application, medical preparations containing active ingredients, diseases, etc., can solve the problems of pathological aging of the female reproductive system that have not yet been prevented, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1 Evaluation of efficacy and safety based on high-throughput standardized cell experiments.
[0031] On the basis of previous work, high-throughput standard cell experiments were used to screen the dosage range of nicotinic acid-based derivatives such as nicotinamide, nicotinic acid, nicotinamide riboside and nicotinamide mononucleotide.
[0032] Based on the previous work of the present invention, on the basis of gradient treatment, the absorbance method was used to measure cell viability, ATP production, intracellular ROS level and β-galactosidase activity, and the average value was taken as the effect index on the basis of normalization of the above data , based on the data of 5 independent experiments, the T-test analysis was carried out; with P0.01 Dose as the toxicity dose threshold of the component. The data show that the effective range, optimal dose and toxicity threshold of several representative nicotinic acid-based derivatives are nicotinamide (10-50...
Embodiment 2
[0033] Example 2 Effect experiment on premature ovarian failure animal model mice.
[0034] Based on the optimal dose obtained in Example 1, the recovery of estrogen in mice was measured. Three independent experiments with 120 mice found that the pretreatment group was 21.6% higher than the negative control group, and the T test found that the difference was significant. The above data indicate that the nicotinic acid-based derivatives can effectively increase the estrogen level in premature ovarian failure animal model mice.
Embodiment 3
[0035] Example 3 A randomized double-blind controlled multi-center volunteer experiment of this formula at an optimal concentration.
[0036] From June 2018 to October 2019, in Beijing, Xi'an and Xianyang, a total of 150 female premature ovarian failure volunteers were selected, with an average age of 36.2 years and a body mass index of 21.9. Volunteers were externally applied niacin-based derivatives whose appearance could not be distinguished, and marketed products B and C for 120 days (formulation A was given the optimal dose according to Example 1, and products B and C were taken according to the instructions). Volunteer experiments were conducted on the principle of double-blind control.
[0037] Serum estrogen levels, menstrual status, and serum follicle-stimulating hormone levels of volunteers were measured, and the above results were normalized to generate a score for female reproductive system impairment. The results showed that formula A could finally reduce volunte...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com